Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of a Series B extension 3round of financing. The additional capital is earmarked to support the company's double-digit organic growth and strategic investments in key operational assets.

Experic, a contract development and manufacturing organization (CDMO) and pharmaceutical supply services company, supports every phase of a product's life cycle from conception to clinical and commercial scale, across a range of dosing and packaging formats, including tablets, pellets, capsules, and low dose dry powder inhalation. From our state-of-the-art, Class A cGMP facility, we manage global delivery of the highest quality products, even for expedited projects, while providing unparalleled knowledge, expertise, and customer service.